INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice

INTRODUCTION: Real-world trial data comparing single- with multiple-inhaler triple therapy (MITT) in COPD patients are currently lacking. The effectiveness of once-daily single-inhaler fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) and MITT were compared in usual clinical care. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpin, David M.G., Worsley, Sally, Ismaila, Afisi S., Beeh, Kai-Michael, Midwinter, Dawn, Kocks, Janwillem W.H., Irving, Elaine, Marin, Jose M., Martin, Neil, Tabberer, Maggie, Snowise, Neil G., Compton, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181617/
https://www.ncbi.nlm.nih.gov/pubmed/34109236
http://dx.doi.org/10.1183/23120541.00950-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181617/
https://www.ncbi.nlm.nih.gov/pubmed/34109236
http://dx.doi.org/10.1183/23120541.00950-2020

Ejemplares similares